In phase I and II trials, urolithin A was safe and improved muscle endurance in older people, but the primary walking outcome was not met.
Confidence
Debated
Level of evidence
●●●●●○ Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
DysbiosisUrolithin A
What the sources say
Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).